Showing results (171-180 of 256) with videos related to

Sort By:
Pageof 26
Antimicrobial Agents and Chemotherapy|May 1, 1991
In vitro activity and in vivo efficacy of a new series of 9-deoxo-12-deoxy-9,12-epoxyerythromycin A derivativesD J Hardy, R N Swanson, N L Shipkowitz, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|June 27, 2009
Linguistic history of posterior reversible encephalopathy syndrome: mirror of developing knowledgeZeev V Maizlin, Hournaz Ghandehari, Leonid Maizels, et al.
Prosthetics and Orthotics International|March 13, 2015
Evaluation of an instrument-assisted dynamic prosthetic alignment technique for individuals with transtibial amputationCaroline Wen Jia Chen, Winfried Heim, Karen Fairley, et al.
Pathogens (Basel, Switzerland)|July 28, 2026
Geographic Distribution and ORF5 Diversity of PRRSV-2 Variants in Midwestern U.S. Diagnostic Submissions, 2023-2025Ramchander Nadipelly, Mohamed Selim, Jagathiswaran Radhakrishnan, et al.
Acta Clinica Belgica|January 1, 1995
Epidemiology and laboratory diagnosis of hantavirus (HTV) infectionsJ Clement, P McKenna, J Groen, et al.
BMC Bioinformatics|July 26, 2016
A novel approach for multi-SNP GWAS and its application in Alzheimer's diseasePaul M Bodily, M Stanley Fujimoto, Justin T Page, et al.
The Journal of Antibiotics|March 1, 1997
Production of brominated tiacumicin derivativesJ E Hochlowski, M Jackson, R R Rasmussen, et al.
Gynecologic Oncology|July 21, 2004
Eukaryotic initiation factor 5A-1 (eIF5A-1) as a diagnostic marker for aberrant proliferation in intraepithelial neoplasia of the vulvaBernadette M Cracchiolo, Debra S Heller, Paul M J Clement, et al.
Acta Clinica Belgica|January 1, 1995
[Epidemic of hantavirus disease in Entre-Sambre-et-Meuse: year 1992-1993. Clinical and biological aspects]P Colson, P Damoiseaux, J Brisbois, et al.
Pageof 26